Epithelix offers two travel grants for LIVe2026
Each grant is €500. Applications are due by 15 August 2026, targeting early-career researchers presenting at the congress.
See the latest news and media coverage for Epithelix. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of in vitro respiratory models
epithelix.comLast updated
In short: Epithelix prepared for the LIVe2026 congress, marked its 20th anniversary, and participated in global research on in-vitro lung models.
Each grant is €500. Applications are due by 15 August 2026, targeting early-career researchers presenting at the congress.
Authors can now view their submission outcome and register via the dashboard.
The congress covers eight themes on in vitro lung models and offers travel grants and poster awards for early career researchers.
Dedicated to viral exacerbations of asthma and COPD, it develops in vitro models alternative to animals to test innovative treatments. Funded by Auvergne-Rhône-Alpes Region, with Rheonova and RESPIVIR.
The research report on the global In-vitro Lung Model Market examines the current and future development estimates of the market. This report provides comprehensive information on the In-vitro Lung Model Market, which in the current market situation...
The global market for In Vitro Lung Model estimated at US$494.6 Million in the year 2022, is projected to reach a revised size of US$1.8...
Geneva - The PETA International Science Consortium Ltd. and Epithelix Sàrl are pleased to award three researchers three-dimensional tissue models that will be used to...
Track Epithelix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.